t(14;19)(q32;q13): A recurrent translocation in B-cell precursor acute lymphoblastic leukemia

被引:23
作者
Robinson, HM [1 ]
Taylor, KE [1 ]
Jalali, GR [1 ]
Cheung, KL [1 ]
Harrison, CJ [1 ]
Moorman, AV [1 ]
机构
[1] Univ Southampton, Southampton Gen Hosp, Leukaemia Res Fund Cytogenet Grp, Canc Sci Div, Southampton SO16 6YD, Hants, England
关键词
D O I
10.1002/gcc.10299
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The recurrent t(14; 19)(q32; q13) translocation associated With chronic B-cell lymphoproliferative disorders, such as atypical chronic lymphocytic leukemia, results in the juxtaposition of the IGH@ and BCL3 genes and subsequent overexpression of BCL3. We report six patients with B-cell precursor acute lymphoblastic leukemia who have a cytogenetically identical translocation with different breakpoints at the molecular level. Fluorescence in situ hybridization with locus-specific probes confirmed the involvement of the IGH@ gene but showed that the breakpoint on 19q13 lay outside the region documented in t(14; 19)(q32; q13)-positive chronic lymphocytic leukemia; This newly described tran location constitutes a distinct cytogenetic subgroup that is confined to older children and younger adults with B-cell precursor acute lymphoblastic leukemia. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:88 / 92
页数:5
相关论文
共 28 条
  • [1] [Anonymous], 2003, MITELMAN DATABASE CH
  • [2] Three further cases of t(8;14)(q11.2;q32) in acute lymphoblastic leukemia
    Byatt, SA
    Cheung, KL
    Lillington, DM
    Mazzullo, H
    Martineau, M
    Bennett, C
    Roberts, K
    Harewood, L
    Sumption, N
    Humphreys, M
    Burrett, J
    Harrison, CJ
    [J]. LEUKEMIA, 2001, 15 (08) : 1304 - 1305
  • [3] The Medical Research Council trials in adult acute lymphocytic leukemia
    Durrant, IJ
    Richards, SM
    Prentice, HG
    Goldstone, AH
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2000, 14 (06) : 1327 - +
  • [4] MLL2:: A new mammalian member of the trx/MLL family of genes
    FitzGerald, KT
    Diaz, MO
    [J]. GENOMICS, 1999, 59 (02) : 187 - 192
  • [5] The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
    Grimwade, D
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2001, 14 (03) : 497 - 529
  • [6] Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials
    Hann, I
    Vora, A
    Richards, S
    Hill, F
    Gibson, B
    Lilleyman, J
    Kinsey, S
    Mitchell, C
    Eden, OB
    [J]. LEUKEMIA, 2000, 14 (03) : 356 - 363
  • [7] Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol
    Hann, I
    Vora, A
    Harrison, G
    Harrison, C
    Eden, O
    Hill, F
    Gibson, B
    Richards, S
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (01) : 103 - 114
  • [8] Harrison Christine J, 2002, Rev Clin Exp Hematol, V6, P91, DOI 10.1046/j.1468-0734.2002.00069.x
  • [9] The Leukaemia Research Fund/United Kingdom Cancer Cytogenetics Group karyotype database in acute lymphoblastic leukaemia: A valuable resource for patient management
    Harrison, CJ
    Martineau, M
    Secker-Walker, LM
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (01) : 3 - 10
  • [10] KARYOTYPIC AND CLINICAL FINDINGS IN A CONSECUTIVE SERIES OF CHILDREN WITH ACUTE LYMPHOCYTIC-LEUKEMIA
    HEEREMA, NA
    PALMER, CG
    BAEHNER, RL
    [J]. CANCER GENETICS AND CYTOGENETICS, 1985, 17 (02) : 165 - 179